AKBA - Akebia Therapeutics, Inc.

Name: Akebia Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Classified under Pharmaceuticals (Health Care sector), AKBA's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Butler John P.	3.72M	$2.34M	-
VP	Burke Steven Keith	948.4K	$1.32M	-
CFO	Ostrowski Erik	616.6K	$684.4K	-
VP	Rucci Carolyn M.	588.4K	$817.8K	-
Other	Grund Nicholas	561.8K	$780.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 1, 2021	Butler John P.61	CEO and President	Sell	4,109	$3.40	$13,970.60	-0.4%	+13.8%	-79.9%
Apr 1, 2021	Burke Steven Keith61	SVP, Chief Medical Officer	Sell	1,081	$3.40	$3,675.40	-0.6%	+13.8%	-79.9%
Mar 1, 2021	Butler John P.61	CEO and President	Sell	49,990	$3.40	$169,771.04	-4.3%	+1.3%	-36.1%
Mar 1, 2021	Burke Steven Keith61	SVP, Chief Medical Officer	Sell	7,558	$3.40	$25,667.72	-4.5%	+1.3%	-36.1%
Mar 1, 2021	Dahan Michel59	SVP, Chief Operating Officer	Sell	14,547	$3.40	$49,403.07	-5.4%	+1.3%	-36.1%
Mar 1, 2021	Hadas Nicole R.60	SVP, Chief Legal Officer	Sell	14,285	$3.40	$48,513.29	-5.1%	+1.3%	-36.1%
Mar 1, 2021	Faulkingham Dell70	CCO	Sell	6,749	$3.40	$22,920.28	-5.0%	+1.3%	-36.1%
Jun 8, 2020	Gowen Maxine	Director	Sell	4,567	$12.05	$55,032.35	-15.9%	-	-
Jun 8, 2020	Gilman Steven C70	Director	Sell	4,567	$12.08	$55,169.36	-10.5%	-	-
Jun 8, 2020	Smith Cynthia	Director	Sell	4,567	$12.10	$55,260.70	-10.8%	-	-

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC